Paul Muir joined Avilar Therapeutics in May 2022, as Senior Manager, Strategy and Portfolio Development. He focuses on analysis of key pipeline assets and assessment of therapeutic opportunities in support of portfolio decision-making and development of the company’s strategic plan. He was previously a consultant at ClearView Healthcare Partners where he worked with stakeholders across the biopharma industry on projects including indication prioritization, due diligence, and business development strategy. Paul received his PhD in molecular, cellular, and developmental biology from Yale University and a BS in biological engineering from MIT.
